Clever Leaves International Inc. (“Clever Leaves” or the “Company”), a leading multi-national operator (MNO) and licensed producer of pharmaceutical-grade medical cannabis and hemp extracts, today announced the first closing of its Series E financing at US$14 million, bringing the Company’s total funding to over US$120 million. Cowen served as exclusive placement agent for the financing and a majority of the Series E capital was invested by leading institutional investors with a demonstrated track record in the sector.